]>
IRCT20191231045966N1 IRCT 2021-07-18 Tehran University of Medical Sciences Effect of mobile application on drug use in older adults An investigation of the drug management application effect on drug adherence and consequences in older adults 2021-08-23 anticipated 192 Complete https://irct.ir/trial/57549 interventional Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Supportive, Randomization description: The present study is a randomized clinical trial that will be conducted to determine the effect of drug management application on drug adherence and consequences in older adults. The study population is all community older adults who take five or more drugs in their daily medication regimen and were referred to the elderly clinic in Ziaian Hospital. The method isØ› after obtaining permission to conduct research from the Ethics Committee of the School of Nursing and Midwifery and Rehabilitation with IR.TUMS.FNM.REC.1400.068 ID, the researcher will choose among the elderly who referred to this center and meet the inclusion criteria, then the samples are randomly assigned to the experimental and control groups by random blocking method. To perform randomization, 192 samples are selected by the available sampling method, and using the random blocking method, they are assigned in two groups of control and intervention. Depending on the sample size, 48 blocks of 4 (or 32 blocks of 6) are required for random block allocation. The intervention group will be displayed with A and the control group with B. The website https://www.Randomization.com will be used for random blocking method, Blinding description: Due to blinding random allocation from the researcher, a dark envelope sample size is prepared and each of created random groups will be written on a card and put inside the envelope. At the beginning of the registration of individuals, according to the order of arrival of the samples, one of the envelopes is opened in order and the assigned group of that sample is specified. N/A Hypertension. Intervention 1: Intervention group: The drug application is installed on the intervention group's mobile phone, and reminders about when to take the drugs will be set. Intervention 2: Control group: Control group receives the usual care of the center and no intervention is made for them. But at the end of the study, in order to observe the research ethics and if the application is effective on the drug adherence of the intervention group, this program will be installed on their smartphone and the method of using it will be taught. Yes - There is a plan to make this available What will be shared: In this study, all the information obtained after completing the Morisky Drug Adherence Questionnaire and the researcher-made Drug Consequences Questionnaire can be shared after identifying individuals. When: Access period starts 6 months after the results are published To whom: Researchers working in academic and scientific institutions Conditions: All researchers working in academic and scientific institutes can use the results of this study without any preconditions. Where to obtain: Shahzad Pashaeypoor Associate Professor of Nursing Department of Community Health and Geriatric Nursing, School of Nursing & Midwifery Tehran University of Medical Sciences 00989124913843 Pashaeypoor.sh@gmail.com Zipcode: 1419733171 How to obtain: Without providing any specific documentation, the information will be available to them as soon as possible in the form of the specified instructions. Comments:
public Shahzad Pashaeypoor
School of Nursing Midwifery ,Tehran University of Medical Sciences Nosrat st. Tohid sq. Tehran .IRAN
Tehran Iran (Islamic Republic of) 1419733171 +98 912 491 3843 pashaeypoor.sh@gmail.com Tehran University of Medical Sciences scientific Shahzad Pashaeypoor
School of Nursing Midwifery ,Tehran University of Medical Sciences Nosrat st. Tohid sq. Tehran .IRAN
Tehran Iran (Islamic Republic of) 141973317 +98 912 491 3843 pashaeypoor.sh@gmail.com Tehran University of Medical Sciences Iran (Islamic Republic of) Age between 60-74 years old Conscious consent to enter the study Taking more than five types of medication during the day Reading and writing literacy Having a smart phone and the ability to use it Ability to communicate and not having dementia Having any of the following diseases: hypertension, diabetes, chronic obstructive pulmonary disease (COPD) Use only the drug form of the tablet (Tab) in the drug program 60 years 75 years Both Reluctance to continue participating in the study Hospitalization or death of the participats Use of rare, expensive and special drugs Use of injectable drugs (such as insulin in diabetes) I10 Essential (primary) hypertension Lifestyle Lifestyle Intervention group: The drug application is installed on the intervention group's mobile phone, and reminders about when to take the drugs will be set. Control group: Control group receives the usual care of the center and no intervention is made for them. But at the end of the study, in order to observe the research ethics and if the application is effective on the drug adherence of the intervention group, this program will be installed on their smartphone and the method of using it will be taught. Drug adherence. Timepoint: In the present study, Morisky Adherence Questionnaire (MAQ) will be completed by both control and intervention groups before the start of the study and after 8 weeks from the beginning of the study. Method of measurement: Morisky Adherence Questionnaire (MAQ). Drug consequences. Timepoint: In the present study, a researcher-made questionnaire on drug consequences before and 8 weeks after the intervention will be completed by the control and intervention groups. Method of measurement: researcher-made drug consequences questionnaire. Tehran University of Medical Sciences Approved 2021-07-17 Research Ethics Committees of School of Nursing and Midwifery & Rehabilitation - Tehran University o School of Nursing and Midwifery & Rehabilitation, Doctor Mirkhani (Eastern Nosrat), Tohid square, District, Tehran provenance Tehran Tehran Iran (Islamic Republic of)